Bruker BioSciences, Applied Biosystems, Europroteome, Power3, SurroMed, RoboDesign International | GenomeWeb

Bruker Expects Revenue Shortfall in Q2

Bruker BioSciences said this week that it estimates a revenue shortfall for the second quarter of this year, causing its stock to lose about 10 percent of its value by Thursday afternoon.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.